Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update

Julia Lee
March 6, 2017

Market Update 3 March

Julia Lee
March 3, 2017

Market Update

Julia Lee
March 2, 2017

How to create a watchscreen

Bell Direct
March 1, 2017

How to set trading alerts

Bell Direct
March 1, 2017

How to transfer your shares to Bell Direct

Bell Direct
February 27, 2017

How to get a stock quote

Bell Direct
February 27, 2017

February newsletter Julia’s insights

Julia Lee
February 24, 2017

CEO interview – Cobalt Blue

Bell Direct
February 21, 2017

Your Money Your Call

Julia Lee
February 14, 2017

Your Money Your Call

Julia Lee
February 7, 2017